235.1 Dosing rC1 and rC2 collagenases based on percent parenchymal mass improves digestion efficacy of fibrotic chronic pancreatitis pancreases intended for pediatric islet auto-transplantation
Mr. Krishna Kumar Samaga, United States
235.2 Optimization of Islet Isolation Methodology with Data Modeling and Decision Support
235.4 New pancreatic islet purification method in pancreatic islet isolation applying photoimmunotherapy.
Mr. Koya Shinohara, Japan
235.5 SEPAX -SEFIA a repurposed closed system for human islet purification and processing in cGMP environment
Julie Kerr-Conte, France
235.6 Novel models for predicting the volume and the cell content of individual islets from 2D-microscopic projections for islet graft quality control.
Dr. David Habart, Czech Republic
235.7 Analysis of collagenase dose on allogeneic islet isolation outcomes and glucose-stimulated insulin release
Mr. Doug O'Gorman, Canada
235.8 Quantitative analysis of microbial contamination in islet isolation for total pancreatectomy and islet auto transplantation (TPIAT): development of bioburden reduction strategies